TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change From Baseline in Simpson-Angus Scale (SAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change From Baseline in Abnormal Involuntary Movement Scale (AIMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Blood Pressure (systolic and diastolic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Depression Symptoms (Patient Health Questionnaire 9)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Physical Activity Regimen
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Child hyperactivity/inattention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child emotional problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility of serial cerebrospinal fluid collections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child engagement
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Child initiation of within-screen joint attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child initiation of across-screen joint attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grandparent Sensitivity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parental Involvement
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Intraoperative PCI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Absolute change in Brief Pain Inventory (BPI) worst pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of positive screening test for bladder cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Southampton Score Self Management Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hypertension Self-care Activity Level Effects
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hypertension Knowledge Level Scale Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Coronal balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of the tibia and femur
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tibiofemoral angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee joint line convergence angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower limb mechanical axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Mental Health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fluctuation in mood disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluctuation in academic stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of CT head scan reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleeping problems
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Parental stress scale (PSS)
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Efficacy of fractional CO2 laser in treatment of melasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Safety of fractional CO2 laser in treatment of melasma
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Who Measured Blood Pressure as Instructed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants Who Understood Blood Pressure Readings
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Evaluation of Blood Pressure Reading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: patient-reported outcomes (Pros)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: All-cause admission ratio
Endpoint domain: Mortality/survival
Primary endpoint: Death ratio
Endpoint domain: Mortality/survival
Primary endpoint: Antibiotic use ratio
Endpoint domain: Resource use
Primary endpoint: Interoceptive accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interoceptive sensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interoceptive awareness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Staphylococcus aureus spine implant associated infections correctly identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in MENSA titers in the post-operative period
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MENSA titers in spine implant infections compared to S. aureus infections of other orthopedic sites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Acute radiation dermatitis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Crown retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Patient/family interest
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EndeavorRx training adherence rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reports of technical ease-of-use and satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Gait and Balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Stand Up and Go Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving an Investigator's Global Assessment (IGA) Score of 0 or 1 and >= 2-Grade Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of first stage of Labour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perinatal results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency of use of the partograph
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changes in Suicidality Assessed Using the Columbia-Suicide Severity Rating Scale (C-SSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With Clinically Significant Findings in Extrapyramidal Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Count of number of times engaged in Condomless Anal Intercourse (CAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of drinks per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial blood Insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial Glucagon Like Peptide -1 Total (GLP-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain during shoulder flexion movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ultrasound elastography results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prevalence of fetal brain anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of fetal nervous system anomalies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Romberg Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Vestibular Disorders Activities of Daily Living Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: silent parenchymal and vascular brain changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average slide duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosed infection post liver transplantation
Endpoint domain: Adverse events/effects
Primary endpoint: Inadequate prep rate
Endpoint domain: Adverse events/effects
Primary endpoint: Walking Index of Spinal Cord Injury (WISCI II) Overall Measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability in fetal heart rate extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reliability in maternal heart rate extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Re-Admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Serum levels of CA19-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Postoperative morphine equivalent consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with undetectable HIV viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prescribed PPI dose over 12 months follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: upper gastrointestinal symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative Opioid Consumption in Oral Morphine Equivalent (OME) (mg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Borg Rating of Perceived Exertion (RPE)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Volume of fat retained
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of antitumor activity using RECIST v1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence, severity and seriousness of treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in B12 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: vitamin D concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: parathyroid hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Thenar Muscle Cross-Sectional Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: AUCt of CKD-388, D418
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of CKD-388, D418
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of immunogenicity parameter from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants With Treatment-emergent Adverse Events (TEAEs) as a Measure of Severity
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Preferring to Use Placebo Intravaginal Ring A versus Ring B
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Satisfaction with Placebo Intravaginal Ring Use
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dose limiting toxicity (DLT) after GC012F infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse Events (AE) after infusion
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Response Rate (ORR) as assessed by the investigator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Failure Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximum Plasma Concentration (Cmax) of Livmoniplimab and Budigalimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Serum Concentration Versus Time Curve (AUC) of Livmoniplimab and Budigalimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children receiving timely vaccinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite rate of all death, all stroke, systemic embolism, and ISTH major bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Cough Stress Test Assessment Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom Severity/Toxicity Index
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Perception Test Independent of Motor Skills-4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct Identification of Pre-Treatment Images Compared to Follow Up Images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Investigator Global Assessment of Performance (IGAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with a return to home after hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Predictive value of early blood gene expression signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knee flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Average knee pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: NIH-CPSI total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood loss control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Patient participant reported experience of colonoscopy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient participant reported barriers to colonoscopy
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Colonoscopist participant perceptions of the patient experience of colonoscopy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Recurrence/exacerbation of psoriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Rate of total non-hematologic Grade ≥3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and duration of new adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence and duration of new serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: HIV Stigma Framework Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Substance Use Mechanism Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: aortic strain (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: aortic stiffness index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: aortic distensibility (cm2.dyn-1.10-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Vasopressors dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of asynchronies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimation of transpulmonary pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in abdominal pain/discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in global abdominal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knee angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hip angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of days till diastema appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain experience during activation of expander by visual analogue scale (VAS)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: 1-year RFS rate
Endpoint domain: Mortality/survival
Primary endpoint: Levels of relaxation and wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effect of MDI on motor function at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EtCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Central nervous system (CNS)-progression free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Phe values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Self-care of Chronic Illness Inventory Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood product requirement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of subjects with TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: TEAEs rates per injection
Endpoint domain: Adverse events/effects
Primary endpoint: TEAEs rates per subject year
Endpoint domain: Adverse events/effects
Primary endpoint: Change in ADASCog-14
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visual Photosensitivity Threshold (VPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough Concentration of Macitentan and Aprocitentan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent tumor coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Intramyocardial hemorrhage (IMH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Volume of Intramyocardial hemorrhage (IMH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline in the Roche digital biomarker score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum and peritoneal fluid mannose-binding lectin-associated serine protease-3 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum and peritoneal fluid adipsin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum and peritoneal fluid properdin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum and peritoneal fluid complement factor H level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anemia at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of participants with complete clearance of AKs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre-discharge mortality
Endpoint domain: Mortality/survival
Primary endpoint: Any grade BPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: longitudinal clinical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Oral Apremilast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite clinical and serological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Fugl-Meyer assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Systolic / Diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Transthoracic echocardiography (TTE) score at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Success of epidural localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Multidimensional sleep health (MSH) composite
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: CPAP adherence rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Measurement of peri-implant soft tissues volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target lesion restenosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Amount of Midazolam used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence of retinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: 3 month Complete Response Rate (CRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Email productivity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Digital wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants With PR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FFR auditory encoding measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language developmental outcomes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: regional compliance using EIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes